NO20075540L - Lignian-inneholdende sammensetninger - Google Patents

Lignian-inneholdende sammensetninger

Info

Publication number
NO20075540L
NO20075540L NO20075540A NO20075540A NO20075540L NO 20075540 L NO20075540 L NO 20075540L NO 20075540 A NO20075540 A NO 20075540A NO 20075540 A NO20075540 A NO 20075540A NO 20075540 L NO20075540 L NO 20075540L
Authority
NO
Norway
Prior art keywords
compositions
lignian
containing compositions
isofiavone
lignan
Prior art date
Application number
NO20075540A
Other languages
English (en)
Norwegian (no)
Inventor
Mark W Empie
Brent D Flickinger
Sam Z Sun
Original Assignee
Archer Daniels Midland Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Archer Daniels Midland Co filed Critical Archer Daniels Midland Co
Publication of NO20075540L publication Critical patent/NO20075540L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/55—Linaceae (Flax family), e.g. Linum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
NO20075540A 2005-04-04 2007-11-01 Lignian-inneholdende sammensetninger NO20075540L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66793705P 2005-04-04 2005-04-04
PCT/US2006/012209 WO2006107820A2 (en) 2005-04-04 2006-04-03 Lignan-containing compositions

Publications (1)

Publication Number Publication Date
NO20075540L true NO20075540L (no) 2007-11-01

Family

ID=36636653

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20075540A NO20075540L (no) 2005-04-04 2007-11-01 Lignian-inneholdende sammensetninger

Country Status (10)

Country Link
US (1) US20060234948A1 (zh)
EP (1) EP1876914A2 (zh)
JP (1) JP2008537678A (zh)
CN (1) CN101188948A (zh)
AU (1) AU2006232344A1 (zh)
BR (1) BRPI0607651A2 (zh)
CA (1) CA2604595A1 (zh)
IL (1) IL186093A0 (zh)
NO (1) NO20075540L (zh)
WO (1) WO2006107820A2 (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008012106A1 (en) 2006-07-28 2008-01-31 Bioriginal Food & Science Corporation Fat containing composition
JP2008239619A (ja) * 2007-02-28 2008-10-09 Fuji Chem Ind Co Ltd 末梢血行改善組成物
CN101854812B (zh) * 2007-09-14 2014-04-23 Tic树胶公司 超可分散性胶质和粉末以及它们的制备方法
US8283338B2 (en) 2007-11-30 2012-10-09 Kao Corporation GIP secretion inhibitor
SE532965C2 (sv) * 2008-02-06 2010-05-25 Edio Healthcare Ab Förfarande för framställning av mikropartiklar innehållande växtsterol
JP4409617B1 (ja) * 2008-12-04 2010-02-03 富士化学工業株式会社 カロテノイド色素の退色防止方法及びその容器体
CA2751511C (en) 2009-02-23 2017-04-11 Unilever Plc Edible composition for treating cutaneous signs of ageing
US8338389B2 (en) 2009-06-17 2012-12-25 Kao Corporation Agent for preventing or ameliorating obesity
JP4647712B1 (ja) * 2010-04-30 2011-03-09 富士化学工業株式会社 アスタキサンチンを含む練粉焼成食品
ITPI20110034A1 (it) * 2011-04-01 2012-10-02 Funcional Food Res S R L Preparazione alimentare funzionale ad uso femminile.
WO2013075120A1 (en) * 2011-11-18 2013-05-23 Regents Of The University Of Minnesota Methods of treating cancer with herbacetin
JP6051436B2 (ja) * 2011-12-07 2016-12-27 国立研究開発法人産業技術総合研究所 レッドクローバーと亜麻種子由来のエストロゲン類似活性組成物
US20150098978A1 (en) * 2013-10-03 2015-04-09 Altria Client Services Inc. Dissolvable-chewable tablet
EP3171741A1 (en) * 2014-07-21 2017-05-31 Abbott Laboratories Nutrient delivery system
CN108324757A (zh) * 2018-05-17 2018-07-27 山西大学 胡麻多酚的提取方法及抗肿瘤应用
US11173187B2 (en) * 2018-11-13 2021-11-16 Immortazyme Company Ltd. Concentrated oil-based polyphenol composition and a method of producing the oil-based polyphenol composition
CN110367259A (zh) * 2019-06-25 2019-10-25 山东省农业科学院作物研究所 一种小麦玉米周年高产抗逆栽培调控剂及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2234479A (en) * 1936-03-13 1941-03-11 Robert P Scherer Capsule and method of making the same
US2349430A (en) * 1941-05-15 1944-05-23 Eastman Kodak Co Medical capsule
US2387747A (en) * 1944-03-04 1945-10-30 Benjamin C Cowley Machine for and a method of making filled capsules
GB591442A (en) * 1944-07-08 1947-08-18 Kurt Posner Improvements in or relating to the manufacture of capsules containing a liquid
DE1617671C3 (de) * 1967-03-07 1980-07-03 A. Nattermann & Cie Gmbh, 5000 Koeln Weichgelatine-Kapseln mit erhöhter Wärmestabilität
YU36434B (en) * 1969-05-14 1984-02-29 Sanol Arznei Schwarz Gmbh Process for obtaining gelation capsules filled with the active substance resistant to gastric juice and dissolvable in the small intestine
US4028024A (en) * 1974-10-31 1977-06-07 Moreland Stephen T Manufacture of filled capsules or the like
JPS6229515A (ja) * 1985-07-30 1987-02-07 Shinjiro Tsuji 硬カプセル剤のフイルムコ−テイング方法
US4816259A (en) * 1987-02-12 1989-03-28 Chase Chemical Company, L.P. Process for coating gelatin capsules
US4935243A (en) * 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
US5146758A (en) * 1991-03-04 1992-09-15 Herman Norman L Process of producing soft elastic gelatin capsules
GB9226238D0 (en) * 1992-12-16 1993-02-10 Scherer Ltd R P Encapsulation apparatus and process
US5827256A (en) * 1995-04-21 1998-10-27 Kimberly-Clark Worldwide, Inc Tampon having a protective finger sheath and a method of forming
US6261565B1 (en) * 1996-03-13 2001-07-17 Archer Daniels Midland Company Method of preparing and using isoflavones
US6248354B1 (en) * 1999-03-04 2001-06-19 Allergan Sales, Inc. Capsule system
US6767565B2 (en) * 2001-03-22 2004-07-27 Archer Daniels Midland Company Process for obtaining lignan
US20030060420A1 (en) * 2001-09-14 2003-03-27 Rick Heintzman Process for extraction and stabilization of phytoestrogens from flaxseed and product therefrom
KR101029223B1 (ko) * 2002-03-11 2011-04-14 산토리 홀딩스 가부시키가이샤 Ｓｄｇ의 제법 및 그 배합 음식물
US20050079247A1 (en) * 2003-10-14 2005-04-14 Slilaty George E. Food composition and method of making same

Also Published As

Publication number Publication date
AU2006232344A1 (en) 2006-10-12
WO2006107820A2 (en) 2006-10-12
BRPI0607651A2 (pt) 2009-09-22
CA2604595A1 (en) 2006-10-12
CN101188948A (zh) 2008-05-28
US20060234948A1 (en) 2006-10-19
IL186093A0 (en) 2008-01-20
EP1876914A2 (en) 2008-01-16
JP2008537678A (ja) 2008-09-25
WO2006107820A3 (en) 2007-05-24

Similar Documents

Publication Publication Date Title
NO20075540L (no) Lignian-inneholdende sammensetninger
Seeram Berry fruits: compositional elements, biochemical activities, and the impact of their intake on human health, performance, and disease
Calò et al. Protective effect of Vaccinium myrtillus extract against UVA-and UVB-induced damage in a human keratinocyte cell line (HaCaT cells)
M Brown et al. Mechanisms underlying the anti-proliferative effects of berry components in in vitro models of colon cancer
Pruteanu et al. The biochemistry and effectiveness of antioxidants in food, fruits, and marine algae
AR048181A1 (es) Composicion de ingredientes funcionales
BRPI0507593A (pt) composições contendo cis-isÈmeros de um composto carotenóide e processo
WO2008153945A3 (en) Nutraceutical co-crystal compositions
WO2007114945A3 (en) Compositions and methods for enhancing the antioxidant status of animals
Tselepi et al. Catalytic inhibition of eukaryotic topoisomerases I and II by flavonol glycosides extracted from Vicia faba and Lotus edulis
WO2012038512A3 (en) Composition comprising sod, lutein and zeaxanthin
WO2006063443A3 (en) Supplement dietary composition for promoting weight loss
Bodhade et al. Chemoprevention of premalignant and malignant lesions of oral cavity: Recent trends
Khandelwal et al. Protective effects of common anthocyanidins against genotoxic damage induced by chemotherapeutic drugs in mice
JP2006111541A (ja) 葛花処理物を含有する経口用肌質改善剤
Diaconeasa et al. Anthocyanins-smart molecules for cancer prevention
WO2007109071A3 (en) Hydroxylated polymethoxyflavone compositions
Rho et al. Anti‐Inflammatory Effect of By‐Products from Haliotis discus hannai in RAW 264.7 Cells
Rudolfová et al. Effect of selected catechins on doxorubicin antiproliferative efficacy and hepatotoxicity in vitro
Chusri et al. Antioxidant, anticancer, and cytotoxic effects of Thai traditional herbal preparations consumed as rejuvenators
WO2010080414A3 (en) Substituted fno (2-[furan-2-yl] naphthalen-1-ol) derivatives as anti-cancer agents
WO2006089211A3 (en) Combat/training antioxidant micronutrient formulation and method of administration
Ajila et al. Role of dietary antioxidants in cancer
DE602005010256D1 (de) Produkt pflanzlichen ursprungs, das proanthocyane enthält, sowie verfahren zu seiner herstellung
Radhai Sri et al. Versatile health benefits of active components of grapes (Vitis vinifera)

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application